In cell and mouse studies, CBG reduced the growth of colorectal-cancer cells and slowed chemically-induced colon-tumor development, an effect linked to TRPM8 blockade. This is strictly preclinical — not tested in humans and not a therapy.
The grade weighs the claim as a whole, across every study our registry holds on the question. How good any one of those papers is remains a separate matter, and you can judge each on its own terms.
in vitro + animal (CRC cells; mouse colon cancer models) · animal
One more study on this question is still in intake review. It joins the citations and the grade only if it clears its review.
The CBG monograph covers the compound end to end, and the gap-map charts the questions nobody has tested yet.
CBG acts on α2-adrenoceptors, which help regulate blood pressure; anyone taking cardiovascular medication should consult a clinician before using CBG products. Nothing on this page is medical advice, and no statement here is a claim that CBG treats, cures, or prevents any condition. Grades are based on the studies we had checked as of 9 August 2026. Report a safety event. Peregrine Biopharma funds the platform and holds no editorial authority.